Tilray | TRLY - Market Capitalization

Stock Price
10.85
Daily Change
0.49 4.73%
Monthly
-9.88%
Yearly
835.34%
Q1 Forecast
10.37

Tilray reported $8.18B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 322M 180M Jun/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Avita Medical AUD 140.79M 194.8M Jun/2025
Canopy Growth CAD 136.67M 644.68M Feb/2026
Cronos Group USD 1.06B 319.22M Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.62T 72.34B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Moderna USD 16.5B 6.41B Feb/2026
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Organon & Co USD 1.89B 29.17M Feb/2026
Revvity USD 12.58B 1.61B Feb/2026
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 11.54B 1.06B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026